Effectiveness of a third BNT162b2 mRNA COVID-19 vaccination during pregnancy: a national observational study in Israel | Nature Communications
Omicron BA.1/1.1 SARS-CoV-2 Infection among Vaccinated Canadian Adults | NEJM
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine - ScienceDirect
Boosting immunity to COVID-19 vaccines | Nature Medicine
Phases and Eligibility
COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR
Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials -
Should You Get a COVID Booster or Third Dose? – Cleveland Clinic
Top 3 COVID-19 vaccine questions – Booster dose after AZ, booster dose timing and are boosters mandatory | Australian Government Department of Health and Aged Care
Jacareí amplia vacinação contra a Covid-19 para crianças de 3 e 4 anos e inicia aplicação da quarta dose para quem tem mais de 18 anos - Prefeitura Municipal de Jacareí
Bivalent Boosters and Additional Doses - Delaware's Coronavirus Official Website
Vaccin anti-Covid : le délai pour la dose de rappel passe à 3 mois, y a-t-il un impact sur le pass sanitaire ? - midilibre.fr
Veterinária burla sistema e toma três doses de vacinas contra Covid-19; Prefeitura de Guarulhos pede apuração do MP | São Paulo | G1
What Does a Multi-Dose Series Mean for the COVID-19 Vaccination Effort? | KFF
Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study - The Lancet Microbe
Third COVID Vaccine Dose Could Be the Last | MedPage Today
What Immunocompromised People Should Know About the Third COVID-19 Vaccine Dose
Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study - The Lancet Rheumatology
Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants | Nature Communications
Dosing Schedule for GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant)
Six-month follow-up of a booster dose of CoronaVac in two single-centre phase 2 clinical trials | Nature Communications
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors | Nature Medicine
Hepatitis B Foundation: Hepatitis B Vaccine Schedules